PLSEPulse Biosciences, Inc.
24.31USD-3.44%Mkt Cap: 1.70B USDP/E: Last update: 2026-06-01

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…

Indicators:|

Key Statistics

Company
Market Cap1.70B USD
Enterprise Value1.67B USD
Revenue (TTM)751.00K USD
Gross Profit-189.00K USD
Net Income (TTM)-72.78M USD
Revenue/Share0.0110 USD
Last Price24.31 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS74587B1017
Valuation
P/E (Trailing)
P/E (Forward)-28.41
PEG
EV/EBITDA-21.86
EV/Revenue2223.40
P/S2303.92
P/B21.03
EPS (TTM)-1.10
EPS (Forward)-0.88
52W Range
12.5676% of range27.98
52W High27.98 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-4775.56%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-54.12M USD
CapEx (TTM)335.00K USD
FCF Margin-3872.19%
FCF Yield-1.71%
Net Debt-61.16M USD
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity0.09
Current Ratio7.26
Quick Ratio6.99
Book Value/Sh1.189 USD
Cash/Share0.9870 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)30.00 USD
Target Range30.00 USD30.00 USD
# Analysts2
Ownership
Shares Out.69.21M
Float18.34M
Insiders73.38%
Institutions11.56%
Short Interest
Short Ratio9.2d
Short % Float16.75%
Short % Out.4.65%
Shares Short3.22M
Short (prev mo.)2.91M
Technical
SMA 5022.15 (+9.8%)
SMA 20017.92 (+35.6%)
Beta1.63
S&P 52W Chg27.70%
Avg Vol (30d)320.11K
Avg Vol (10d)419.51K
Technical Indicators
RSI (14)57.0
MACD1.1339
MACD Signal1.0385
MACD Hist.+0.0953
BB Upper29.13 USD
BB Middle23.23 USD
BB Lower17.33 USD
BB Width50.78%
ATR (14)1.704 USD
Vol Ratio (20d)0.31x